In Good Company with Nicolai Tangen cover image

Stephane Bancel CEO of Moderna

In Good Company with Nicolai Tangen

00:00

Addressing Diversity in Vaccine Trials

This chapter addresses the challenges of achieving demographic diversity in a phase three vaccine clinical trial. It emphasizes efforts to enhance African-American representation and tackles the historical mistrust that affects participation in health studies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app